Drug Discovery

Selvita provides its clients with effective drug discovery support based on broad capabilities and deep experience in small molecule drug discovery, starting from target validation up to the selection of a clinical candidate. We powerfully execute fully-integrated drug discovery programs combining all of Selvita’s core skills in biology and chemistry or else provide partially-integrated or stand-alone services utilising selected capabilities optimally matched to the specific needs of our clients.

Selvita is built on robust capabilities and experience in assay development and screening, high-throughput screening, high content screening, medicinal and synthetic chemistry, computer-aided drug design, structural biology, in vitro and in vivo pharmacology, ADME/DMPK, toxicology and analytical testing. In collaboration with proven and experienced partners, we also offer pharmacological and efficacy testing with in vivo models of disease available for variety of indications. Our daughter company, Ardigen, supports us in increasing the speed and reducing the cost of drug discovery process by using Artificial Intelligence tools.

Selvita has already proven its impact on the global innovation. Through a great number of projects executed for over 10 years, we have contributed to impactful discoveries in various areas. Our scientific team have built strong partnerships on out-of-the-box thinking and become an integral part of our clients’ organizations ensuring, strong IP protection and goal achievement.

Regulatory studies

Being a versatile contract research organization, for over a decade Selvita has been providing also world-class pharma services in the field of drug testing and bioanalytical analyses. We offer services at every stage of the drug development process, from development and validation of methods, stability studies, to routine quality control testing.

The quality of our services has been repeatedly confirmed during the GMP and GLP inspections. Obtained GMP and GLP certificates additionally prove that services provided by Selvita are performed in accordance with the highest standards of the pharmaceutical industry, and cover all services offered by our laboratories.

We are located in Krakow having a total area of 4,000 m² (laboratory and office spaces) of which approximately 800 m² are GxP-certified laboratory spaces. The GxP spaces are divided between two departments: cell and molecular biology and analytical laboratories. Both departments provide analytical services to the pharmaceutical industry, especially in the quality control area. In addition to being equipped with state-of-the-art analytical devices, the cell and molecular biology laboratory works under the biosafety level 2 regime. All laboratory activities are conducted under Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) and according to valid ICH guidelines.

Research & Development

Since its inception in 2007, Selvita has developed into a major research and development organization with a global network of customers. Although drug discovery remains the flagship activity for the company, significant portion of our business is dedicated to a broad range of other research and development activities, particularly the pharma and agrochemical companies.

We have a dedicated Process Research group, which serves a variety of clients ranging from Big Pharma to biotech to manufacturers of generics. Our chemists undertake even the most challenging synthetic projects, regardless of the scale. Within multidisciplinary project teams involving chemists, computational chemists and biologists we are ready to face the challenges of finding compounds with defined biological activity .